Last reviewed · How we verify
Kanion Capsule
Kanion Capsule, developed by Lianyungang Kanion Group, Ltd., is a small molecule analgesic currently in Phase 2 clinical trials for primary menstrual pain. It has no FDA approval and limited trial data, but shows potential for treating endometriosis.
At a glance
| Generic name | Kanion Capsule |
|---|---|
| Sponsor | Lianyungang Kanion Group, Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kanion Capsule CI brief — competitive landscape report
- Kanion Capsule updates RSS · CI watch RSS
- Lianyungang Kanion Group, Ltd. portfolio CI